tiprankstipranks
3 Best Stocks to Buy Now, 10/1/2024, According to Top Analysts 
PremiumMarket News3 Best Stocks to Buy Now, 10/1/2024, According to Top Analysts 
3M ago
Savara announces EAP for molgramostim for patients with aPAP
Premium
The Fly
Savara announces EAP for molgramostim for patients with aPAP
3M ago
Savara appoints Braden Parker as chief commercial officer
Premium
The Fly
Savara appoints Braden Parker as chief commercial officer
3M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
6M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
6M ago
Savara price target raised to $10 from $8 at Guggenheim
Premium
The Fly
Savara price target raised to $10 from $8 at Guggenheim
6M ago
Savara reports results from pivotal Phase 3 IMPALA-2 clinical trial.
PremiumThe FlySavara reports results from pivotal Phase 3 IMPALA-2 clinical trial.
6M ago
Savara price target raised to $11 from $9.50 at Oppenheimer
Premium
The Fly
Savara price target raised to $11 from $9.50 at Oppenheimer
7M ago
Savara price target lowered to $7 from $10 at Evercore ISI
Premium
The Fly
Savara price target lowered to $7 from $10 at Evercore ISI
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100